Tender

Provision of a Framework Agreement for Nuclear Medicine Radiopharmacy Services and Consumables

UNIVERSITY COLLEGE LONDON HOSPITALS NHS FOUNDATION TRUST (UCLH)

This public procurement record has 1 release in its history.

Tender

19 Aug 2019 at 16:04

Tender Notice
Summary of the contracting process

The University College London Hospitals NHS Foundation Trust (UCLH) is seeking submissions for the "Provision of a Framework Agreement for Nuclear Medicine Radiopharmacy Services and Consumables." This competitive procurement is currently in the Tender stage and will culminate in a contract awarded to the highest scoring supplier for three identified lots: UCLH Managed Services, Managed Services, and Radiopharmaceutical Consumables. The tender period closes on 16th September 2019, and the resulting contract is expected to commence on 1st April 2020, running through to 31st March 2030. The procurement method employed is a selective negotiated procedure within the healthcare services industry.

This tender presents a substantial opportunity for businesses in the nuclear medicine and healthcare supply sectors, particularly those who can provide innovative and flexible services. It is particularly well-suited for suppliers offering managed services and radiopharmaceutical consumables that can meet the stringent requirements of NHS Trusts. Given the emphasis on on-site production and quick turnaround for isotopes, small to medium enterprises (SMEs) with capacity to deliver specialised services in a partnership-oriented manner would be especially competitive in this procurement process.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Provision of a Framework Agreement for Nuclear Medicine Radiopharmacy Services and Consumables

Notice Description

University College London Hospitals NHS Foundation Trust (the "Authority"), is issuing this tender in connection with a Competitive with Negotiation Procedure Procurement for the Provision of a Framework Agreement for Nuclear Medicine Radiopharmacy Services and Consumables for University College London Hospitals NHS Foundation Trust (the "Contract"), and the subsequent call off of Radiopharmacy Services and Consumables(the "Call Offs") from the Contract by the Authority. This procurement and resulting single supplier Framework Agreement contains three lots: Lot 1: UCLH Managed Services Lot 2: Managed Services Lot 3: Radiopharmaceutical Consumables The highest scoring supplier will be awarded all three lots, resulting in a single supplier Framework Agreement.Where the Authority wishes to call off from this Framework Agreement, a separate contract will be entered into for the services under each lot. The Framework Agreement will be available to the Authority and all other NHS Trusts. For a detailed list of all NHS Trusts please see https://www.nhs.uk/servicedirectories/pages/nhstrustlisting.aspx. UCLH provides first-class acute and specialist services in six hospitals in central London. During 2019 and 2020 UCLH will be opening two new hospital sites: Opening in September 2019, a specialist centre for services currently at the Eastman Dental and Royal National Throat Nose and Ear Hospitals.Opening in 2020, a new facility which includes Europe's largest centre for blood disorders, short stay surgery and a national proton beam therapy centre. Further information relating to the non-PFI estate can be found in the data pack issued with this ITPN and in the Service Matrix. The Institute of Nuclear Medicine (INM) carries out radionuclide imaging investigations and therapies for the purposes of clinical diagnosis, treatment and research. It is the largest single site department in the UK and currently undertakes some 17,000 studies per annum. INM provide a wide range of "state of the art" nuclear medicine imaging services including: * General nuclear medicine including in-vitro tests; * Single-Photon Emission Computed Tomography (SPECT) / with x-ray Computed Tomography (CT) (SPECT/CT); * Ultra-fast dedicated cardiac SPECT; * Positron Emission Tomography/Computed Tomography (PET/CT); * Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) (first in the UK) In addition, INM also perform a range of routine and experimental inpatient and outpatient radionuclide therapy procedures, with access to ten dedicated radionuclide therapy beds. The Authority is looking to enter into a new contract that is able to provide an innovative and flexible approach. It is seen as imperative that there is an on-site element to this contract in order to maintain an efficient and effective working partnership with tangible benefits for both parties. In particular certain isotopes would continue to benefit form on site production due to their limited shelf life.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-b3e05b27-a95f-47eb-9f91-b717aa3e785d
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/ed953617-a9d3-4238-8ced-552e38cd9f9a
Current Stage
Tender
All Stages
Tender

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Services
Procurement Method
Selective
Procurement Method Details
Negotiated procedure
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

85 - Health and social work services

CPV Codes

85149000 - Pharmacy services

Notice Value(s)

Tender Value
£20,000,000 £10M-£100M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
19 Aug 20196 years ago
Submission Deadline
16 Sep 2019Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
31 Mar 2020 - 31 Mar 2030 Over 5 years
Recurrence
Not specified

Notice Status

Tender Status
Active
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
UNIVERSITY COLLEGE LONDON HOSPITALS NHS FOUNDATION TRUST (UCLH)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
W1T 7NF
Post Town
West London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI3 Inner London - West
Small Region (ITL 3)
TLI36 Camden
Delivery Location
Not specified
Local Authority
Camden
Electoral Ward
Bloomsbury
Westminster Constituency
Holborn and St Pancras

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-b3e05b27-a95f-47eb-9f91-b717aa3e785d-2019-08-19T17:04:02+01:00",
    "date": "2019-08-19T17:04:02+01:00",
    "ocid": "ocds-b5fd17-b3e05b27-a95f-47eb-9f91-b717aa3e785d",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "LPPUCLH1-DN426162-67449643",
        "title": "Provision of a Framework Agreement for Nuclear Medicine Radiopharmacy Services and Consumables",
        "description": "University College London Hospitals NHS Foundation Trust (the \"Authority\"), is issuing this tender in connection with a Competitive with Negotiation Procedure Procurement for the Provision of a Framework Agreement for Nuclear Medicine Radiopharmacy Services and Consumables for University College London Hospitals NHS Foundation Trust (the \"Contract\"), and the subsequent call off of Radiopharmacy Services and Consumables(the \"Call Offs\") from the Contract by the Authority. This procurement and resulting single supplier Framework Agreement contains three lots: Lot 1: UCLH Managed Services Lot 2: Managed Services Lot 3: Radiopharmaceutical Consumables The highest scoring supplier will be awarded all three lots, resulting in a single supplier Framework Agreement.Where the Authority wishes to call off from this Framework Agreement, a separate contract will be entered into for the services under each lot. The Framework Agreement will be available to the Authority and all other NHS Trusts. For a detailed list of all NHS Trusts please see https://www.nhs.uk/servicedirectories/pages/nhstrustlisting.aspx. UCLH provides first-class acute and specialist services in six hospitals in central London. During 2019 and 2020 UCLH will be opening two new hospital sites: Opening in September 2019, a specialist centre for services currently at the Eastman Dental and Royal National Throat Nose and Ear Hospitals.Opening in 2020, a new facility which includes Europe's largest centre for blood disorders, short stay surgery and a national proton beam therapy centre. Further information relating to the non-PFI estate can be found in the data pack issued with this ITPN and in the Service Matrix. The Institute of Nuclear Medicine (INM) carries out radionuclide imaging investigations and therapies for the purposes of clinical diagnosis, treatment and research. It is the largest single site department in the UK and currently undertakes some 17,000 studies per annum. INM provide a wide range of \"state of the art\" nuclear medicine imaging services including: * General nuclear medicine including in-vitro tests; * Single-Photon Emission Computed Tomography (SPECT) / with x-ray Computed Tomography (CT) (SPECT/CT); * Ultra-fast dedicated cardiac SPECT; * Positron Emission Tomography/Computed Tomography (PET/CT); * Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) (first in the UK) In addition, INM also perform a range of routine and experimental inpatient and outpatient radionuclide therapy procedures, with access to ten dedicated radionuclide therapy beds. The Authority is looking to enter into a new contract that is able to provide an innovative and flexible approach. It is seen as imperative that there is an on-site element to this contract in order to maintain an efficient and effective working partnership with tangible benefits for both parties. In particular certain isotopes would continue to benefit form on site production due to their limited shelf life.",
        "datePublished": "2019-08-19T17:04:02+01:00",
        "status": "active",
        "classification": {
            "scheme": "CPV",
            "id": "85149000",
            "description": "Pharmacy services"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "countryName": "British Oversea Territories"
                    },
                    {
                        "countryName": "Channel Islands"
                    },
                    {
                        "countryName": "Europe"
                    },
                    {
                        "countryName": "Isle of Man"
                    },
                    {
                        "countryName": "Rest of the World"
                    },
                    {
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 20000000,
            "currency": "GBP"
        },
        "procurementMethod": "selective",
        "procurementMethodDetails": "Negotiated procedure",
        "tenderPeriod": {
            "endDate": "2019-09-16T23:59:59+01:00"
        },
        "contractPeriod": {
            "startDate": "2020-04-01T00:00:00+01:00",
            "endDate": "2030-03-31T23:59:59+01:00"
        },
        "suitability": {
            "sme": true,
            "vcse": false
        },
        "mainProcurementCategory": "services",
        "documents": [
            {
                "id": "1",
                "documentType": "tenderNotice",
                "description": "Opportunity notice on Contracts Finder",
                "url": "https://www.contractsfinder.service.gov.uk/Notice/ed953617-a9d3-4238-8ced-552e38cd9f9a",
                "datePublished": "2019-08-19T17:04:02+01:00",
                "format": "text/html",
                "language": "en"
            }
        ]
    },
    "parties": [
        {
            "id": "GB-CFS-84398",
            "name": "University College London Hospitals NHS Foundation Trust (UCLH)",
            "identifier": {
                "legalName": "University College London Hospitals NHS Foundation Trust (UCLH)"
            },
            "address": {
                "streetAddress": "Floor 4B Maple House, 149 Tottenham Court Road",
                "locality": "London",
                "postalCode": "W1T 7NF",
                "countryName": "England"
            },
            "contactPoint": {
                "email": "samm.parker1@nhs.net"
            },
            "details": {
                "url": "http://www.uclh.nhs.uk"
            },
            "roles": [
                "buyer"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-84398",
        "name": "University College London Hospitals NHS Foundation Trust (UCLH)"
    }
}